Thoratec Hopes MCAC Will Follow Blues’ Lead To Cover Destination LVADs
This article was originally published in The Gray Sheet
Executive Summary
Thoratec expects to meet with the Medicare Coverage Advisory Committee in early March to discuss expanding coverage of the HeartMate SNAP-VE left-ventricular assist device to include destination therapy for end-stage heart failure patients